Neumora Therapeutics Earnings
NASDAQ: NMRAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
0.4798+0.0115 (+2.46%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 0.4825 +0.56%
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.19
Neumora Therapeutics earnings summary
Neumora Therapeutics is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $-0.19.
Summary generated from market data by MetaCap's automated system. Methodology